Category:Drug discoveries

Subcategories

This category has the following 15 subcategories, out of 15 total.

Media in category "Drug discoveries"

The following 86 files are in this category, out of 86 total.

• 
  1-generations.png 547 × 232; 4 KB
  
• 
  2-generations.png 503 × 249; 4 KB
  
• 
  3-generations.png 503 × 230; 4 KB
  
• 
  5-HT2C-hit-derivative2.svg 802 × 782; 21 KB
  
• 
  5-HT2C-hit-derivative5.svg 720 × 750; 19 KB
  
• 
  5-HT2C-hit-general.svg 644 × 590; 21 KB
  
• 
  5th generation.png 3,837 × 532; 33 KB
  
• 
  A-New-Trade-Framework-for-Global-Healthcare-R&D-pbio.0020052.g001.jpg 433 × 289; 16 KB
  
• 
  A-New-Trade-Framework-for-Global-Healthcare-R&D-pbio.0020052.g002.jpg 584 × 705; 58 KB
  
• 
  ACT-1102.PNG 2,066 × 1,137; 171 KB
  
• 
  Agonist.1.sh.jpeg 886 × 523; 50 KB
  
• 
  Agonist.2.sh.png 897 × 523; 33 KB
  
• 
  Alison Howe Price, M.D.jpg 997 × 1,133; 331 KB
  
• 
  AmilorideAnalogues.jpg 1,318 × 228; 39 KB
  
• 
  Analogues of peramivir.jpg 454 × 151; 9 KB
  
• 
  Antisense Oligonucleotide Use in ncRNA therapy.png 720 × 504; 90 KB
  
• 
  Arbdrugdesign.jpg 1,364 × 1,772; 162 KB
  
• 
  Automated Screening (38709119951).jpg 5,759 × 3,839; 3.52 MB
  
• 
  Basic structure of cephalosporins.png 503 × 226; 4 KB
  
• 
  Cannabinoid CB1 Receptor.png 618 × 439; 98 KB
  
• 
  Chronology-TLP.png 1,259 × 358; 41 KB
  
• 
  Cinnamides SAR.jpg 1,533 × 339; 96 KB
  
• 
  Clasificación de los tipos de inhibidores .png 1,005 × 613; 125 KB
  
• 
  Clinical development of TRPV1 antagonists.jpg 2,071 × 1,344; 290 KB
  
• 
  Conception de medicament-histoire-02.jpg 498 × 162; 60 KB
  
• 
  Conception de medicament-histoire-03.jpg 497 × 132; 38 KB
  
• 
  Conception de medicament-phases-01.jpg 338 × 64; 22 KB
  
• 
  Cycle 3,4 vágott.jpg 262 × 291; 38 KB
  
• 
  DARTS.png 3,111 × 1,167; 436 KB
  
• 
  Denovo.gif 601 × 393; 6 KB
  
• 
  Development of MK-869.sr.svg 459 × 981; 29 KB
  
• 
  Development of MK-869.svg 512 × 1,356; 106 KB
  
• 
  Development of MK869.jpg 427 × 1,102; 49 KB
  
• 
  DHFR methotrexate.jpg 767 × 598; 77 KB
  
• 
  Docking.png 500 × 158; 9 KB
  
• 
  Dr. Atul Kumar India.JPG 1,200 × 1,600; 697 KB
  
• 
  Drug discovery cycle 2.png 720 × 540; 63 KB
  
• 
  Drug discovery cycle-ca.svg 820 × 666; 28 KB
  
• 
  Drug discovery cycle.svg 900 × 675; 175 KB
  
• 
  Drug discovery research workflow - journal.pbio.1001379.g001.png 2,050 × 1,182; 116 KB
  
• 
  Drug Evaluation Process.jpg 1,433 × 507; 76 KB
  
• 
  Flow chart for structure based drug design.jpg 1,487 × 1,240; 143 KB
  
• 
  FlowchartMMP.PNG 436 × 664; 15 KB
  
• 
  Forward and reverse pharmacology.jpg 602 × 491; 63 KB
  
• 
  Gamma analogs.png 2,254 × 700; 43 KB
  
• 
  Glibenclamide Ahmadi 2013.svg 512 × 379; 40 KB
  
• 
  Glycorandomization Scheme.png 806 × 288; 14 KB
  
• 
  Greek drug discovery.jpg 1,132 × 1,280; 433 KB
  
• 
  Identification-of-Novel-Functional-Inhibitors-of-Acid-Sphingomyelinase-pone.0023852.g001.jpg 430 × 316; 59 KB
  
• 
  Identification-of-Novel-Functional-Inhibitors-of-Acid-Sphingomyelinase-pone.0023852.g002.jpg 404 × 312; 47 KB
  
• 
  Identification-of-Novel-Functional-Inhibitors-of-Acid-Sphingomyelinase-pone.0023852.g003.jpg 430 × 335; 59 KB
  
• 
  Immobilization Strategies for Target Identification.png 4,842 × 2,091; 823 KB
  
• 
  Infographic – High-throuput screening.jpg 2,000 × 1,536; 1.24 MB
  
• 
  Kavalactiones.png 434 × 621; 38 KB
  
• 
  Koz US6150376.png 2,171 × 1,273; 65 KB
  
• 
  LCM cell capturing from brain.jpg 513 × 379; 220 KB
  
• 
  Ligand Probe Crosslinker Immobilization.png 3,000 × 3,057; 629 KB
  
• 
  LONG ROAD TO A NEW DRUG.jpg 555 × 391; 100 KB
  
• 
  Melatonin timeline.jpg 468 × 274; 31 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g001.jpg 661 × 825; 181 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g002.jpg 661 × 843; 342 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g003.jpg 661 × 859; 150 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g005.jpg 661 × 808; 167 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g006.jpg 654 × 893; 257 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g007.jpg 498 × 407; 72 KB
  
• 
  Metabolomics-Driven-Nutraceutical-Evaluation-of-Diverse-Green-Tea-Cultivars-pone.0023426.g008.jpg 661 × 843; 170 KB
  
• 
  MTOR complexes.png 684 × 270; 84 KB
  
• 
  Product pipeline TRPA1.gif 1,047 × 689; 106 KB
  
• 
  Professor Christopher Abell FMedSci FRS (cropped).jpg 720 × 960; 449 KB
  
• 
  Professor Christopher Abell FMedSci FRS.jpg 960 × 1,440; 722 KB
  
• 
  Renin inhibitor timeline..png 1,524 × 544; 120 KB
  
• 
  Retrometabolic Drug Design loop.gif 960 × 720; 66 KB
  
• 
  Selective estrogen receptor modulator timeline.svg 311 × 463; 13 KB
  
• 
  Small Molecule Drugs for the Treatment of Myotonic Dystrophy Type 1 (DM1).png 635 × 541; 192 KB
  
• 
  SPROX.png 3,111 × 1,167; 445 KB
  
• 
  Structural Biology and Drug Discovery.png 1,356 × 580; 318 KB
  
• 
  Structure-Based Drug Discovery Processs.jpg 340 × 685; 38 KB
  
• 
  Target identification by chromatographic co-elution.png 3,518 × 850; 340 KB
  
• 
  Target Validation in Peptide Drug Discovery.png 822 × 368; 31 KB
  
• 
  Thermal Proteome Profiling.png 4,058 × 4,972; 1.02 MB
  
• 
  Thrombin binding sites.tiff 298 × 139; 26 KB
  
• 
  Timeline of ncRNA therapeutics.jpg 720 × 504; 96 KB
  
• 
  Timeline-SNRIs-2010.png 599 × 244; 9 KB
  
• 
  TLP-MOA.png 1,024 × 792; 102 KB
  
• 
  Tubulin inhibitors binding site.png 635 × 337; 24 KB
  
• 
  Yfirlitsmynd.jpg 1,807 × 1,583; 221 KB